April 2, 2021
April 2, 2021 – The U.S. FDA has approved Qelbree® (viloxazine) extended-release oral capsules, manufactured by Supernus Pharmaceuticals, to treat attention
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
April 1, 2021
April 1, 2021 – The U.S. FDA has approved a new indication for Tyvaso® (treprostinil), manufactured by United Therapeutics, to treat patients who have pulmonary
April 1, 2021
April 1, 2021 – The U.S. FDA has approved a new indication for Praluent® (alirocumab), manufactured
by Regeneron. The drug is now indicated to treat homozygous familial
April 1, 2021
April 1, 2021 – The U.S. FDA has authorized Moderna’s COVID-19 vaccine to be kept at room temperature for up to 24 hours once removed from the refrigerator for
March 31, 2021
March 29, 2021
- Eraxis (anidulafungin) – for yeast infections of the blood, stomach, or esophagus
- Lyrica CR (pregabalin extended release) – for nerve pain due to diabetes or shingles
March 31, 2021
March 31, 2021 – The U.S. FDA has issued a safety communication for lamotrigine, a drug used to treat seizures and bipolar disorder. The product is available as a generic
March 31, 2021
March 31, 2021 – The U.S. FDA has approved a new indication for Sarclisa® (isatuximab),
manufactured by Sanofi. The drug is now indicated for use in
March 30, 2021
March 30, 2021 – The U.S. FDA has approved an expanded indication for Vyxeos® (daunorubicin/cytarabine), manufactured by Jazz Pharmaceuticals. The drug is now indicated to treat